Capital International Investors Gossamer Bio, Inc. Transaction History

Capital International Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$8.63 - $10.94 $1.88 Million - $2.38 Million	-217,388 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$8.3 - $13.59 $36.7 Million - $60.2 Million	-4,426,173 Reduced 95.32%	217,388 $2.1 Million
Q3 2020 Nov 13, 2020	SELL	$11.3 - $14.75 $5.81 Million - $7.59 Million	-514,390 Reduced 9.97%	4,643,561 $57.6 Million
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $17.9 Million - $30.1 Million	1,882,100 Added 57.45%	5,157,951 $67.1 Million
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $57.6 Million - $78.5 Million	3,275,851 New	3,275,851 $71 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $65.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.